3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
- RxCUI
- 847213
- RxNorm name
- 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
- Display name
- 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
- Full name
- 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021018 | Humalog Mix 50/50 | insulin lispro protamine and insulin lispro | 351(a) | Disc | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Humalog Mix50/50 KwikPen | INSULIN LISPRO | Eli Lilly and Company | b34cd3ff-d0af-4852-b4ef-2a8b4a93aeae | 2026-01-13 | Warnings, Adverse reactions | 847213 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b34cd3ff-d0af-4852-b4ef-2a8b4a93aeae | HumaLOG Mix 50/50 in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix] [SBD] · Humalog Mix 50/50 300 UNT per 3 ML KwikPen [SY] · Humalog Mix 50/50 300 UNT per 3 ML Prefilled Pen [SY] | 4 | 54 | These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999 | 20260113 |